Results 51 to 60 of about 621,052 (254)

Clinical and economic efficacy of ribosomal therapy in children in the prevention of acute respiratory infections

open access: yesМедицинский совет, 2015
The article tells about the problem of acute respiratory infections in preschool children. Pharmacoeconomic efficacy of ribosomal immunomodulatory therapy for the prevention of acute respiratory infections is evaluated.
A. L. Zaplatnikov   +5 more
doaj   +1 more source

Interventions to facilitate shared decision making to address antibiotic use for acute respiratory infections in primary care [PDF]

open access: yes, 2015
Background: Shared decision making is an important component of patient-centred care. It is a set of communication and evidence-based practice skills that elicits patients' expectations, clarifies any misperceptions and discusses the best available ...
Beller, Elaine M.   +4 more
core   +1 more source

Management of acute bronchitis in healthy adults. [PDF]

open access: yes, 2004
Acute respiratory infections (ARIs) are the most common infections in humans, accounting for half of all acute conditions each year in the United States. Acute bronchitis episodes represent a significant portion of these illnesses.
Aagaard, Eva, Gonzales, Ralph
core  

Incidence of viral respiratory infections in a prospective cohort of outpatient and hospitalized children aged ≤5 years and its associated cost in Buenos Aires, Argentina [PDF]

open access: yes, 2015
Background: Although information about the incidence of viral respiratory illnesses and their associated cost can help health officials explore the value of interventions, data are limited from middle-income countries.
Azziz Baumgartner, Eduardo   +6 more
core   +1 more source

SYMPTOMATIC THERAPY OF COUGH DURING SEASONAL INCREASE OF ACUTE RESPIRATORY INFECTIONS PREVALENCE

open access: yesВопросы современной педиатрии, 2014
Cough is the main symptom of the respiratory tract disorders. Mostly it occurs in viral, bacterial and mixed (viral and bacterial) respiratory tract infections.
K. S. Volkov   +4 more
doaj   +1 more source

DOPE: D-Optimal Pooling Experimental design with application for SARS-CoV-2 screening [PDF]

open access: yesarXiv, 2021
Testing individuals for the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen causing the coronavirus disease 2019 (COVID-19), is crucial for curtailing transmission chains. Moreover, rapidly testing many potentially infected individuals is often a limiting factor in controlling COVID-19 outbreaks.
arxiv  

Acute respiratory virus infections. [PDF]

open access: yesBMJ, 1973
Most of the acute respiratory disease seen in general practice every winter is caused by viruses. The main aim of research over the last 20 years has been to find out if one particular type of virus could be incriminated as the commonest cause of all the varied climcalrnanifestations of acute respiratory disease (A.R.D.) and the main cause of death, so
openaire   +3 more sources

Emerging dominant SARS-CoV-2 variants [PDF]

open access: yesarXiv, 2022
Accurate and reliable forecasting of emerging dominant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants enables policymakers and vaccine makers to get prepared for future waves of infections. The last three waves of SARS-CoV-2 infections caused by dominant variants Omicron (BA.1), BA.2, and BA.4/BA.5 were accurately foretold by our
arxiv  

Optimization of the therapy of ARVI and influenza in outpatient practice

open access: yesЛечащий Врач
Background. Acute respiratory viral infections are a pathology that most often occurs in outpatient therapeutic practice (about 40 million cases per year). The term acute respiratory viral infection is a collective concept and denotes a group of diseases
D. S. Sukhanov   +3 more
doaj   +1 more source

Hubungan Karakteristik Rumah dengan Kejadian Ispa pada Balita dalam Keluarga Perokok di Kelurahan Gundaling I Kecamatan Berastagi Kabupaten Karo Tahun 2014 [PDF]

open access: yes, 2014
Acute Respiratory Infections (ARIs) is a major cause of morbidity and mortality in communicable disease in world especially for children under 5 years old. Children under 5 years old is vulnerable in Acute Respiratory Infections (ARIs).
Lingga, R. N. (Raja)   +2 more
core  

Home - About - Disclaimer - Privacy